These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12352930)

  • 21. Prediction of maintenance oral theophylline dosage using single oral doses in patients with obstructive airways disease.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1983 Nov; 16(5):511-6. PubMed ID: 6639837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of optimum oral theophylline dose in patients with obstructive airways disease.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1983 Jun; 15(6):689-94. PubMed ID: 6871068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers.
    Burkhardt O; Stass H; Thuss U; Borner K; Welte T
    Clin Pharmacokinet; 2005; 44(9):969-76. PubMed ID: 16122283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The bioavailability of 4 sustained-release theophylline preparations from the Chilean market].
    Biagini L; Zamora P; Chávez H; Saavedra I
    Rev Med Chil; 1990 Nov; 118(11):1241-6. PubMed ID: 2152650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The accuracy of a pharmacokinetic theophylline predictor using once daily dosing.
    Chrystyn H; Mulley BA; Peake MD
    Br J Clin Pharmacol; 1987 Sep; 24(3):301-7. PubMed ID: 3663446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.
    Rivington RN; Calcutt L; Hodder RV; Stewart JH; Aitken TL
    Am J Med; 1988 Jul; 85(1B):48-53. PubMed ID: 3041826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage].
    Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative bioavailability and in vitro in vivo correlation of two sustained release brands of theophylline: tablets and pellets.
    Tulain U; Ur-Rahman N
    Pak J Pharm Sci; 2008 Apr; 21(2):131-8. PubMed ID: 18390443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD.
    Rossi A; Kristufek P; Levine BE; Thomson MH; Till D; Kottakis J; Della Cioppa G;
    Chest; 2002 Apr; 121(4):1058-69. PubMed ID: 11948033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of chronic cadmium exposure on the pharmacokinetics of theophylline and ciprofloxacin in rats.
    Zaghloul IY; Radwan MA; Aly ZH
    J Trace Elem Med Biol; 2007; 21(2):132-7. PubMed ID: 17499154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience with two twice daily slow release theophylline preparations. Relation between serum theophylline concentrations, effectiveness, tolerability and compliance in elderly patients.
    Ruggeri S; Bernocchi D; Berte F; D'Anneo R; Gramolini C
    J Int Med Res; 1987; 15(3):170-8. PubMed ID: 3301457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of diurnal changes in the disposition of theophylline.
    Taylor DR; Duffin D; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1983 Oct; 16(4):413-6. PubMed ID: 6684947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral fenoterol versus sustained release theophylline in adult asthmatics.
    Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacokinetics of theophylline and aminophylline in man.
    Aslaksen A; Bakke OM; Vigander T
    Br J Clin Pharmacol; 1981 Mar; 11(3):269-73. PubMed ID: 7213528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A comparative study of the pharmacokinetics of oral preparations of theophylline].
    Tsoĭ AN; Gneushev ET; Maĭorova EM; Gavrilenko LN; Kunes VG
    Farmakol Toksikol; 1990; 53(5):39-42. PubMed ID: 2253747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative dose study of a theophylline sustained-release tablet formulation after repeated administrations.
    Cova D; Cuglituri G; Rossini L; Bonfardeci G
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):273-5. PubMed ID: 2737795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absolute bioavailability of oral theophylline.
    Hendeles L; Weinberger M; Bighley L
    Am J Hosp Pharm; 1977 May; 34(5):525-7. PubMed ID: 868891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.